Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis by Perry, David C. et al.
Traumatic brain injury is associated with subsequent neurologic 
and psychiatric disease: a meta-analysis
David C. Perry, MD1, Virginia E. Sturm, PhD1, Matthew J. Peterson, PhD4,5, Carl F. Pieper, 
DPH6, Thomas Bullock, BA3, Bradley F. Boeve, MD8, Bruce L. Miller, MD1, Kevin M. 
Guskiewicz, PhD, ATC9, Mitchel S. Berger, MD2, Joel H. Kramer, PsyD1, and Kathleen A. 
Welsh-Bohmer, PhD7
1Department of Neurology, University of California, San Francisco, San Francisco, CA, USA
2Department of Neurosurgery, University of California, San Francisco, San Francisco, CA, USA
3School of Medicine, University of California, San Francisco, San Francisco, CA, USA
4Geriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, Duke 
University, Durham, NC, USA
5Department of Medicine, Duke University, Durham, NC, USA
6Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA
7Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
8Department of Neurology, Mayo Clinic, Rochester, MN, USA
9Department of Exercise and Sport Science, University of North Carolina, Chapel Hill, NC, USA
Abstract
Object—Mild traumatic brain injury (TBI) has been proposed as a risk factor for development of 
Alzheimer’s disease, Parkinson’s disease, depression, and other illnesses. This study’s objective 
was to determine the association of prior mild TBI with subsequent diagnosis (i.e., at least one 
year post-injury) of neurologic or psychiatric disease.
Methods—All studies from 1995–2012 reporting TBI as a risk factor for diagnoses of interest 
were identified by searching PubMed, study references, and review articles. Reviewers abstracted 
the data and assessed study design and characteristics.
Results—57 studies met inclusion criteria. A random effects meta-analysis revealed a significant 
association of prior TBI with subsequent neurologic and psychiatric diagnosis. The pooled odds 
ratio (OR) for TBI on development of any illness was 1.67 (95% CI 1.44–1.93, p<.001). Prior TBI 
was independently associated with both neurologic [OR 1.55 (95% CI 1.31–1.83, p<.001)] and 
psychiatric [OR 2.00 (95% CI 1.50–2.66, p<.001)] outcomes. Analyses of individual diagnoses 
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found higher odds of Alzheimer’s disease, Parkinson’s disease, mild cognitive impairment, 
depression, mixed affective disorders, and bipolar disorder in individuals with previous TBI 
compared to those without TBI. This association was present when examining only studies of mild 
TBI and when considering the influence of study design and characteristics. Analysis of a subset 
of studies found no evidence that multiple TBIs were associated with higher odds of disease than a 
single TBI.
Conclusions—History of TBI, including mild TBI, is associated with the development of 
neurologic and psychiatric illness. This indicates that either TBI is a risk factor for heterogeneous 
pathologic processes or that TBI may contribute to a common pathologic mechanism.
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INTRODUCTION
Since the 1928 description of the “punch drunk” condition,48 there has been speculation 
about a connection between traumatic brain injury (TBI) and late-life neurologic or 
psychiatric illness. Though this syndrome was later referred to as “dementia pugilistica” 
because it was thought to uniquely affect boxers,14 an accumulation of cases in recent years 
have suggested that repeated brain injury in other sports such as football, soccer, and 
wrestling might also predispose to neurodegenerative disease52 and that non-sports-related 
TBI, such as that sustained on the battlefield, can lead to this same illness.30 It has recently 
been proposed that a history of even minor brain injury may predispose certain individuals 
to develop this pathologic process, now referred to as “chronic traumatic encephalopathy” or 
CTE52. The presentation of CTE is variable and may include neurologic and/or psychiatric 
manifestations. The current CTE literature suggests two common syndromes: a behavior and 
mood predominant illness, frequently accompanied by paranoia, which would be diagnosed 
as psychiatric illness and a predominantly cognitive disorder that is frequently diagnosed as 
Alzheimer’s disease 82. A third syndrome, which was emphasized by the prior literature on 
boxers includes motor dysfunction with parkinsonism14. Some CTE cases have also been 
described with motor neuron disease53, 54. Epidemiological study of CTE has been 
significantly limited since it is a pathological, rather than clinical diagnosis, and its presence 
can only be definitively confirmed after death. There is accumulating evidence, however, 
that CTE may be a pathologic process that unites seemingly disparate clinical syndromes 
and reflects a shared vulnerability to cognitive-behavioral-motor dysfunction. Recent studies 
have found support for a relationship between TBI and risk for later development of these 
individual neurologic and psychiatric syndromes. Since James Parkinson himself theorized a 
causative link to trauma in 1817, there has been continuing debate regarding the relationship 
between TBI and Parkinson’s disease,19 with many17, 29, 87 but not all3, 43, 49 studies finding 
a positive association. Epidemiological studies investigating the risk of Alzheimer’s disease 
after TBI have also shown mixed results. Meta-analyses of these studies in 199158 and in 
200324 have shown an elevated risk. Prior TBI has also been associated with a significantly 
elevated risk of frontotemporal dementia70 and although a prior meta-analysis of the risk of 
TBI on development of amyotrophic lateral sclerosis (ALS) showed a mildly elevated risk,11 
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others have disputed the connection.93 Although psychiatric symptoms (e.g., depression and 
anxiety) are common acutely after TBI,6, 35, 40 whether there are protracted psychiatric 
sequelae from earlier-life TBI remains poorly understood.96
Our aim was to determine the association of mild TBI with the later development of those 
neurologic and psychiatric illnesses that have previously been linked to TBI and are 
potential manifestations of CTE. To investigate the wide range of disorders associated with 
prior TBI, we reviewed the literature examining TBI and subsequent neurologic or 
psychiatric diagnoses and performed a meta-analysis according to current guidelines56, 84. 
Consistent with the notion that mild TBI may make certain individuals vulnerable to a 
number of neurologic and psychiatric conditions, we hypothesized that there would be an 
association between all diagnoses and a history of TBI, including mild TBI.
METHODS
Identification of the studies
Searches were conducted in Medline (1995 to February 2012) using a comprehensive search 
strategy. We used two components in each search: component A identified papers with 
keywords “craniocerebral trauma,” “head injury,” “brain injury,” or “concussion.” This was 
combined with component B or component C. Component B identified papers pertaining to 
the neurologic disorders of interest (i.e., “neurodegenerative diseases," "mild cognitive 
impairment," "Alzheimer," "Parkinson," "frontotemporal dementia," "amyotrophic lateral 
sclerosis," "vascular dementia," or "dementia"), and component C identified papers 
pertaining to the psychiatric illnesses of interest (i.e., "anxiety disorders," "mood disorders," 
or "schizophrenia and disorders with psychotic features"). We limited our search to papers in 
English and humans.
Three additional steps were taken to ensure search comprehensiveness: (1) references from 
included papers were reviewed, (2) to avoid any bias toward positive results inherent in the 
search strategy an additional search for “risk factors” for each diagnosis was performed to 
capture studies with weak or null findings that did not include our search terms in their title, 
abstract or keywords, (3) the citation lists in review papers were examined. For papers in 
which the required metrics were not easily identified the authors were contacted. A pair of 
reviewers (a neurologist and a neuropsychologist) discussed all papers at each stage of the 
process (Figure 1). Concordance between the reviewers for determining study inclusion was 
high; in cases of disagreement, studies were discussed until a consensus decision was 
reached. Ethics committee approval was not needed for this study as it included only 
analysis of previously published data.
Broad inclusion criteria
We first applied broad inclusion criteria (developed by a team of expert neurologists, 
neurosurgeons, and neuropsychologists) to select papers for further review.
• Original, peer-reviewed research articles (no case reports)
• Adult subjects over 18 years of age at the time of evaluation (not TBI)
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• Presence of TBI without accompanying structural lesion (e.g., subdural hematoma 
or penetrating brain injury). Though our goal was to specifically examine the effect 
of mild TBI, in order to capture all pertinent studies, at this search stage we broadly 
included studies employing the various definitions and labels that are used to refer 
to minor head trauma (e.g., concussion).
• Presence of neurologic or psychiatric diagnosis
• TBI occurred before the diagnosis of the neurologic or psychiatric disorder (with at 
least 12 months between the TBI and outcome diagnosis, if specified)
Narrow inclusion criteria
Papers that met broad inclusion criteria were next reviewed in detail. In addition to ensuring 
adherence to broad criteria, we also confirmed that they met narrow inclusion criteria. If 
some subjects in a study were reported to have structural lesions, but they could be separated 
from those without lesions, we only included subjects with mild TBI.
1. Presence of neurologic or psychiatric disorder. For neurologic disorders, studies 
must have utilized consensus diagnostic criteria or clinical evaluation. For 
psychiatric disorders, diagnoses were based on either criteria (e.g., DSM-IV) or 
scores from standardized measures (e.g., Beck Depression Inventory).
2. Inclusion of a control group. Included studies were cross-sectional, cohort, or case-
control studies in which all subjects underwent identical assessment and diagnostic 
procedures.
3. TBI preceded neurologic or psychiatric diagnosis. We excluded studies that 
reported that the diagnosis of the neurologic or psychiatric disorder had been made 
less than 12 months post-TBI. For studies in which the date of the TBI was not 
reported, we included studies of subjects with neurologic or psychiatric illness who 
were asked about TBI earlier in life.
4. No redundant subjects across studies. In cases where multiple papers used the same 
study cohort we included the most recent papers to capture the largest sample size. 
If multiple outcome diagnoses were reported in one paper, we included each odds 
ratio (OR) if the diagnoses were mutually exclusive. If the diagnoses were not 
mutually exclusive, in the analyses that examined the association of TBI with any 
neurologic or psychiatric outcome, we chose the broader diagnosis (e.g., dementia 
was preferred over Alzheimer’s disease) or, if that distinction was not possible, we 
chose the diagnosis with the larger number of subjects.
Assessment of study characteristics
We recorded additional data regarding factors that could influence the relationship between 
TBI and outcome diagnoses. These included (1) the rigor with which each study employed a 
12-month TBI-outcome diagnosis interval, (2) the TBI characteristics required in each study 
(e.g., whether subjects met accepted criteria for mild TBI or had any individual symptoms 
such as loss of consciousness), (3) whether the TBI diagnosis was based on patient or 
informant self-report as opposed to being made by a clinician, derived from medical records, 
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or based on diagnostic criteria, (4) the study design (cohort, case-control, or cross-sectional), 
and (5) whether information was provided regarding the number of TBIs sustained by each 
subject. These data were used in subgroup analyses geared towards assessing whether study 
characteristics influenced the meta-analysis results.
Statistical Analysis
Primary analyses—The effect of interest for this meta-analysis was the pooled OR. For 
the majority of the studies (51/57), unadjusted ORs were directly calculated from data 
extraction. Standard errors were calculated from the logarithm of the OR to allow for 
symmetry of the estimate on both sides of unity.23 Where sample sizes were not available 
the published unadjusted ORs were used. We then applied standard meta-analytic 
techniques,34 including weighted estimates of the pooled OR with a 95% confidence interval 
(CI). For those studies where the raw cell frequencies did not exist and only the standard 
error of the OR was available, to provide appropriate weighting of the study in the meta-
analysis, the standard error of the OR was transformed to the standard error of the logarithm 
of the OR by linear interpolation. To determine whether there was significant variation 
among studies, tests of heterogeneity were performed.34 All analyses were conducted using 
SAS v9.3 (Cary, NC).
Subgroup analyses—Since the overall analysis was inclusive of various TBI definitions 
and study characteristics, we next conducted seven additional subgroup analyses to examine 
whether our results differed when pooling studies with more uniformity of TBI assessment, 
TBI diagnostic criteria, and study design. When possible, we selected out only those 
subjects from the total study that met criteria for each subgroup analysis. The result is that 
for some studies a different number of subjects was included in the overall analysis 
compared to each subgroup analysis.
Subgroup 1: Effect of time interval between TBI and diagnosis
1. Clearest interval - To ensure that studies with less stringent guidelines about 
timing of TBI were not significantly impacting our results, we excluded studies 
with the possibility that some subjects had a less than 12 month interval between 
TBI and diagnosis.
Subgroups 2–4: Effect of TBI features and severity
2. Brief loss of consciousness – This subgroup included only studies that required 
that loss of consciousness not exceed 30 minutes. This is the maximum duration 
established in the mild TBI criteria of the American Congress of Rehabilitation 
Medicine, Centers for Disease Control, and World Health Organization10, 42, 59.
3. Required loss of consciousness – We included only studies that required brain 
injury with loss of consciousness. This subgroup considered the effect of TBI 
with a uniform minimum severity.
4. Any mild TBI feature – In order to exclude extremely mild or asymptomatic 
brain injury we performed an analysis including only those studies that required 
the brain injury be accompanied by any one (or more than one) common feature 
Perry et al. Page 5













of mild TBI, including loss of consciousness, post-traumatic amnesia, Glasgow 
Coma Scale (GCS) score ≥13, focal neurological deficit, altered mental status, 
brain injury requiring medical care, or symptoms of the postconcussive 
syndrome (e.g., headache, dizziness, nausea, photo- or phonophobia, fatigue, 
sleep difficulty, blurred vision).
Subgroups 5–6: Effect of study design
5. Excluding self-report - In order to assess the impact of recall bias we conducted 
an additional analysis excluding studies with self-reported TBI.
6. Cohort studies - To eliminate recall bias we also performed an analysis 
including only cohort studies (rather than cross-sectional or case-control).
Subgroup 7: Effect of number of TBI
7. Repeated injury - Because we were also interested in whether there is a dose 
effect of TBI on development of later illness, we conducted an additional 
analysis in which we calculated the odds of neurologic or psychiatric diagnosis 
in subjects with more than one TBI compared to a single TBI using a subset of 
studies that provided this information.
Publication bias analysis—To assess for the effect of publication bias on our results we 
used the Egger method18 to examine whether the logarithm of the included ORs are 
predicted by the standard error, which reflects the sample size. We visually examined funnel 
plots of OR against sample size and the logarithm of the OR against the standard error of the 
logarithm of the OR and quantified the degree of bias by multiple regression. Using standard 
error rather than sample size in funnel plots may provide a more accurate visual depiction of 
whether bias is present83.
RESULTS
57 papers met narrow inclusion criteria and were used in the meta-
analyses
.3, 11, 17, 29, 43, 49, 70, 87 1, 2, 5, 7, 8, 9, 15, 16, 20, 22, 25, 27, 31, 32, 33, 37, 45, 47, 51, 55, 57, 60, 61, 62, 63, 64, 65, 67, 68, 69, 71, 72, 73, 74, 75, 76, 79, 80, 81, 85, 86, 90, 91, 92, 93, 94, 95, 97, 98 
Among the included papers, a sufficient number were found to apply meta-analytic methods 
for the diagnoses of dementia, Alzheimer’s disease, Parkinson’s disease, ALS, mild 
cognitive impairment, depression, psychotic disorders, bipolar disorder, and mixed affective 
disorder (a combined group of depression and anxiety). Insufficient numbers of studies were 
found to calculate a pooled OR for frontotemporal dementia, vascular dementia, or anxiety 
disorders. There was significant heterogeneity among studies (Q = 381.99, df = 58, p<.001), 
justifying the use of the random effects meta-analysis.
Prior TBI was associated with development of any of the neurologic and psychiatric 
illnesses of interest [OR 1.67 (95% CI 1.44–1.93), p<.0001]. This association was found for 
both neurologic [OR 1.55 (95% CI 1.31–1.83, p<.0001)] and psychiatric [OR 2.00 (95% CI 
1.50–2.66, p<.0001)] disease in individuals with TBI, and was also found in the following 
diagnoses: Alzheimer’s disease [OR 1.40 (95% CI 1.02–1.90, p<.05)], Parkinson’s disease 
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[OR 1.45 (95% CI 1.18–1.78, p<.001)], mild cognitive impairment [OR 2.69 (95% CI 1.51–
4.77, p<.001)], depression [OR 2.14 (95% CI 1.65–2.77, p<.0001)], bipolar disorder [OR 
1.85 (95% CI 1.17–2.94, p<.01)], and mixed affective disorder [OR 1.84 (95% CI 1.50–
2.66, p<.0001)]. See Table 1 and Figure 2.
Analyses of subgroups revealed a robust relationship between TBI and remote neurologic 
and psychiatric outcomes. The studies included in each subgroup analysis are specified in 
Table 1. Table 2 includes the features reported in each study regarding the time interval 
between TBI and diagnosis, the TBI features and severity, and the study design. Results of 
the subgroup analyses are reported in Table 3. Overall odds and the independent OR for 
neurologic, but not psychiatric disease remained significant when only including studies 
with the clearest greater than 12-month interval between TBI and diagnosis (Subgroup 1). 
The overall OR was significant among those studies that adhered to mild TBI criteria 
limiting duration of loss of consciousness to less than 30 minutes (Subgroup 2). The overall 
OR and OR for any of the studied neurologic and psychiatric diagnoses were also significant 
when only including studies that required loss of consciousness (Subgroup 3). When 
including studies that required the presence of at least one mild TBI symptom (Subgroup 4), 
the overall OR and OR for any of the neurologic and all psychiatric diagnoses of interest 
remained significant. After eliminating the studies with TBI diagnoses based on self-report 
(Subgroup 5), the overall OR and OR for neurologic disorders remained significant, though 
the OR for psychiatric outcomes no longer reached significance. When only cohort studies 
were included (Subgroup 6), the OR for neurologic outcomes was not significant though the 
overall OR and OR for psychiatric illness remained significant. The odds were not higher 
among those that reported more than one TBI compared to those with a single injury 
(Subgroup 7).
Publication bias analyses did not show evidence of bias in the included studies. Visual 
inspection of a funnel plot based on sample size showed that three studies with large 
samples strongly influenced the appearance (Figure 3A). When these studies are removed a 
more expected funnel shape is appreciated (Figure 3B). Regression indicates that the effects 
size (the logarithm of the OR) is not significantly predicted by the standard error when all 
studies are included (F(1,60)=3.08, p=.08) or when the three large sample studies are 
excluded (F(1,57)=1.11, p=.30, Figure 3C).
DISCUSSION
This meta-analysis supports an association between prior TBI and later diagnosis of the 
relevant neurologic or psychiatric diseases. This association was found independently for 
both neurologic and psychiatric outcomes. Alzheimer’s disease, Parkinson’s disease, mild 
cognitive impairment, depression, mixed affective disorders, and bipolar disorder showed a 
statistically significant association with prior TBI. The magnitude of effect is comparable 
across diagnoses, with mild cognitive impairment, depression, and bipolar disorder having 
the highest OR among those results that reached significance. The OR of Alzheimer’s 
disease in this analysis is comparable to the findings of prior meta-analyses.24, 58 The OR of 
ALS was among the highest in the study, and there was some evidence of an association of 
TBI with dementia and psychotic disorders, but these did not reach statistical significance.
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The overall combined OR for the selected neurologic and psychiatric illnesses and for 
neurologic illness independently in individuals with TBI remained significant when 
including only articles that explicitly specified a minimum 12-month interval between TBI 
and outcome diagnosis. The magnitude of association with psychiatric illness, however, did 
not remain significant. These results suggest that there may be a different time course in 
which psychiatric and neurologic symptoms manifest after TBI. While psychiatric 
symptoms are common in the acute phase after mild TBI6, 21, 35, 40 and some of these may 
be short-lived manifestations of the injury, others may reflect a more sustained susceptibility 
to mental illness. The results of this study suggest that TBI is a risk factor for both remote 
psychiatric and neurologic disease and are consistent with the possibility that both types of 
illness arise secondary to a common shared pathologic mechanism.
We conducted additional subgroup analyses to determine whether TBI characteristics or 
methodological factors would influence our findings. The overall OR of TBI remained 
significant when including only studies that required adherence to typical loss of 
consciousness criteria for mild TBI, the presence of any specific mild TBI symptom, or loss 
of consciousness. Though TBI definitions varied widely among studies, these additional 
analyses support an association of mild TBI with the studied neurologic and psychiatric 
outcomes. A significant OR for combined neurologic and psychiatric outcomes was also 
found when eliminating studies that used self-reported diagnosis of TBI and when including 
only cohort studies. Though statistical significance was lost when assessing the association 
with psychiatric outcomes when eliminating self-report and the odds of neurologic outcomes 
among cohort studies, the magnitudes of the ORs were largely consistent with the main 
analysis, and the change in significance is likely due to the small number of articles in these 
analyses and resulting loss of power rather than reflecting a weaker association due to recall 
bias, though this cannot be excluded. Our analyses also suggest that the finding of an 
association with TBI is unlikely to be due to publication bias, though low power may affect 
the publication bias test.
The results of this meta-analysis support an association of illness with a single TBI. A 
relevant associated question is whether this effect is compounded by multiple TBIs. In our 
analysis of multiple head traumas, the results do not show strong evidence for elevated odds 
of illness associated with having more than one head trauma compared to a single TBI. 
Given that only six studies were included in this analysis, lower power may have influenced 
these results. More research on the relationship between TBI exposure and diagnostic 
outcomes is needed.
The magnitude of the OR of TBI in this meta-analysis is relatively modest, but comparable 
to other strongly implicated risk factors. For example, for Alzheimer’s disease, the 
Apolipoprotein E e4 allele is associated with an OR of 1.80–9.05,41 and obesity with an OR 
of 1.80.4 The OR for pesticide exposure and Parkinson’s disease is 1.94.66 Therefore, the 
presence of a risk factor in an individual does not indicate an inevitable development of 
disease. The ORs found in this study suggest that others factors modify an individual’s 
susceptibility to develop a neuropsychiatric disorder after TBI. These factors are largely 
unknown and worthy of further investigation.
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The fact that multiple neurodegenerative and psychiatric diagnoses are associated with the 
same exposure raises questions about possible mechanisms of shared vulnerability. Trauma 
could predispose the brain to different types of neurodegeneration through common 
mechanisms such as oxidative stress and microglial activation77, 99 or induction of plasma 
proteins associated with degeneration such as MCP-1.36 Trauma might also activate 
molecular pathways leading to specific degenerative diseases, such as the finding that 
Alzheimer’s disease-associated proteins including beta amyloid, beta secretase, presenilin-1, 
and caspase-3 accumulate in axons of brain injured animals.12 Cleaved forms of the tau 
protein, which is associated with Alzheimer’s disease and frontotemporal lobar 
degeneration, accumulate after trauma26 and tau abnormalities after trauma have been found 
to be independent of beta amyloid effects.89 The nature of the TBI could also influence the 
clinical presentation in an individual. For example, boxers may suffer from more torsional 
injury that could injury brainstem structures such as the substantia nigra, leading to 
parkinsonism82. Genetic variation could also help to explain the susceptibility of individuals 
to late-life effects of TBI. For example, apolipoprotein E, which is associated with risk of 
Alzheimer’s disease, has shown a variable interaction with mild TBI.50, 63, 88
An alternate explanation for the association across diagnostic groups is that the various 
clinical presentations could be different expressions of a common pathology28, 78. Although 
CTE has been described as a distinct pathological process, the clinical characterization is not 
clearly established, and case reports suggest cognitive, motor, and psychiatric presentations. 
This phenotypic variability could lead to a diagnosis of dementia, Parkinson’s disease, 
motor neuron disease, or primary psychiatric illness in different individuals. A study of 
causes of death among retired National Football League players found a three-fold higher 
rate of dying from neurodegenerative disease compared to the typical population frequency, 
with Alzheimer’s disease and ALS being the most overrepresented44, which would be 
consistent either a shared vulnerability hypothesis across neurodegenerative diseases or a 
common pathology. This meta-analysis examined clinical, not pathological, studies. Thus, it 
is unknown whether any of the subjects would have shown characteristic CTE pathology 
rather than (or in addition to) the more typical neuropathological features associated with 
their syndromes.
Among the articles that were reviewed, several addressed the association between TBI and 
clinical outcomes among athletes. These articles assessed the risk of Parkinson’s disease 
among retired Thai traditional boxers,46 depression and dementia among retired football 
players,32, 33 ALS or chronic encephalopathy among soccer players,13, 39 and chronic TBI in 
boxers.38 Only two of the articles32, 33 that directly evaluated TBI in sports met strict 
inclusion criteria for this study. The ability of this meta-analysis to inform the questions 
surrounding the long-term consequences of sports-related mild TBI is therefore limited by 
this lack in the existing literature. Further longitudinal studies among athletes with 
appropriate control groups, characterization of head injuries (including severity, number, 
and exposure to repetitive subconcussive trauma), and assessment of late-life neurologic and 
psychiatric outcomes will be needed to address this question.
Several limitations of this meta-analysis warrant consideration. One is the possible bias of 
the included studies. We took several steps to mitigate this possibility. Our search strategy 
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included a variety of epidemiological studies that focused on many possible risk factors, not 
just TBI, thereby capturing negative studies that might otherwise have not been published. 
Our formal analyses also did not support publication bias. Although the strict inclusion 
criteria should reduce this possibility, variation in the studies themselves (e.g., different 
criteria for diagnosis of illness, or co-morbid environmental and genetic factors of the study 
population) limits the generalizability of the results. Variable study quality could also have 
resulted in heterogeneity, and it is possible that the presence of other confounding factors 
could have led to the observed association between TBI and later clinical outcomes. For 
example, patients who sustain a TBI as a result of a fall or motor vehicle accident may have 
other medical comorbidities (e.g., vascular disease or substance abuse) or differences in 
socioeconomic status that could predispose to neurologic or psychiatric illness. Another 
possibility is that the TBI itself could lead to injury of change in lifestyle that could modify 
risk of a mood disorder. Finally, ill patients who fall and suffer TBI may also undergo more 
medical testing and therefore be more likely to receive one of these neurologic or psychiatric 
diagnoses. Only English language studies were reviewed, which could have led to exclusion 
of some relevant studies. In spite of our criteria regarding an interval between TBI and 
illness onset, an alternative explanation for the observed association is that some head 
injuries may have been early manifestations of neurologic or psychiatric disease rather than 
an independent predisposing factor for illness. The authors of one of the studies concluded 
this reverse causality was responsible for their findings. They stratified the interval between 
TBI and diagnosis and found the association between TBI and Parkinson’s was no longer 
present when only looking at TBI that occurred greater than 10 years prior to diagnosis71.
A major strength of this meta-analysis was the inclusion of a variety of different neurologic 
and psychiatric outcomes rather than a single diagnosis. By focusing on diagnoses rather 
than self-reported symptoms or performance on cognitive tests, this study assessed outcomes 
of sufficient magnitude to affect quality of life. The included studies also come from 
countries around the world, allowing for more generalizable results. The literature search 
was comprehensive, making this a rigorous examination of the topic.
CONCLUSIONS
This study supports an association of TBI, including mild TBI, on subsequent development 
of neurologic and psychiatric illness, including Alzheimer’s disease, Parkinson’s disease, 
mild cognitive impairment, depression, mixed affective disorders, and bipolar disorder. Due 
to limitations and heterogeneity in the existing studies, prospective studies with uniform 
assessment will be needed to confirm this result and determine the risk conferred by the 
number and severity of TBI in different settings, such as sports or the military.
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Flow chart depicting study identification and screening
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Individual and pooled odds ratios for all included studies (to be aligned with Table 1).
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Publication bias analysis. (A) Funnel plot of OR versus total sample size. (B) Funnel plot of 
OR versus total sample size after excluding the three studies with largest sample sizes 
(Rugbjerg 2008, Nielson 2001, and Turner 2010). (C) Plot of the logarithm of the OR after 
excluding the three largest sample size studies compared to the standard error of the 
logarithm of the OR showing a regression line and 95% confidence interval with slope that 
is not statistically significantly different from 0.
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  Mild cognitive impairment
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    Unverzagt 2011g . . 2.40 1.34–4.30
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  Pooled OR Neurologic 1.55 1.31–1.83
Psychiatric diagnosis
  Depression
    Malaspina 2001 107/661 22/355 2.61 1.62–4.21
    Polusny 2001b,c,e,g . . 1.47 1.10–1.97
    Silver 2001e 40/243 321/4430 2.27 1.60–3.23
    Holsinger 2002b,c,e,f,g 96/160 387/974 1.51 1.14–2.00























    Guskiewicz 2007e 206/63 1272/893 2.30 1.71–3.08
    Gao 2009 38/497 28/1174 3.21 1.95–5.28
    Mollica 2009d,e 10/3 6/23 12.78 2.65–61.56
    Rajkumar 2009d,e 19/108 33/840 4.48 2.46–8.15
    Vanderploeg 2009b,e,g 36/43 242/505 1.75 1.09–2.79
    Bryant 2010b,c,e,f,g 56/265 77/419 1.15 0.79–1.68
    Pooled OR 2.14 1.65–2.77
  Psychotic disorder
    Malaspina 2001 22/107 22/355 3.32 1.77–6.23
    Nielsen 2001b,e,f 278/7854 3394/78710 0.82 0.72–0.93
    Silver 2001a 12/89 349/4584 1.77 0.96–3.27
    AbdelMalik 2003b 23/44 22/80 1.90 0.95–3.79
    Fann 2004a . . 1.10 0.39–3.10
    Pooled OR 1.57 0.83–2.97
  Bipolar disorder
    DelBello 1999b,c,d,e,g 4/17 3/13 1.02 0.19–5.37
    Malaspina 2001 28/207 22/355 2.18 1.22–3.91
    Silver 2001a 6/51 355/4622 1.53 0.65–3.59
    Pooled OR 1.85 1.17–2.94
  Mixed affective disorder
    Fann 2004b,f,g . . 1.50 0.98–2.30
    Nelson 2007b 76/248 318/2045 1.97 1.49–2.62
    Pooled OR 1.84 1.44–2.36
  Pooled OR Psychiatric 2.00 1.50–2.66
Overall Pooled OR 1.67 1.44–1.93
a
Studies that were not included in the overall analysis or pooled neurologic/psychiatric analyses because diagnostic groups within the study were 
not mutually exclusive. Studies that were included in subgroup analyses:
b
clearest interval between TBI and symptom onset,
c
meeting mild TBI criteria for loss of consciousness,
d
requiring loss of consciousness,
e
requiring at least one mild TBI feature,
f




analysis of risk of repeated TBI
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Table 3
Results of subgroup analyses




Risk of TBI when including only
studies with clearest interval on:
  All neurologic and psychiatric
outcomes 1.75 1.43–2.14 p<.001
  All neurologic outcomes 2.05 1.55–2.71 p<.001
  All psychiatric outcomes 1.38 0.95–2.00 p=.09
Risk of TBI when including only
studies meeting mild TBI
requirements for maximum
duration of loss of consciousness 1.54 1.18–2.01 p=.001
Risk of TBI when including only
studies requiring associated loss of
consciousness on:
  All neurologic and psychiatric
outcomes 1.69 1.18–2.44 p<.01
  All neurologic outcomes 1.33 1.00–1.75 p<.05
  All psychiatric outcomes 4.09 1.36–12.32 p=.01
Risk of TBI when including only
studies requiring a mild TBI
feature on:
  All neurololgic and psychiatric
outcomes 1.70 1.42–2.05 p<.0001
  All neurologic outcomes 1.67 1.36–2.07 p<.0001
  All psychiatric outcomes 1.81 1.23–2.66 p<.01
Risk of TBI when eliminating
studies with TBI diagnosis based
on self-report on:
  All neurologic and psychiatric
outcomes 1.62 1.14–2.31 p<.01
  All neurologic outcomes 2.38 1.01–5.62 p<.05
  All psychiatric outcomes 1.18 0.81–1.71 p=.39
Risk of TBI when including only
cohort studies on:
  All neurologic and psychiatric
outcomes 1.38 1.02–-1.87 p<.05
  All neurologic outcomes 1.27 0.72–2.25 p=.41
  All psychiatric outcomes 1.45 1.23–1.71 p<.0001
Risk of multiple TBIs vs one TBI
on any outcome diagnosis 1.10 0.72–1.70 p=.65
J Neurosurg. Author manuscript; available in PMC 2017 February 01.
